4//SEC Filing
Chevallard Daniel R. 4
Accession 0001706176-26-000002
CIK 0001815776other
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 4:21 PM ET
Size
8.8 KB
Accession
0001706176-26-000002
Insider Transaction Report
Form 4
Chevallard Daniel R.
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2026-01-02+84,200→ 84,200 totalExercise: $16.00Exp: 2036-01-01→ Common Stock (84,200 underlying) - Award
Restricted Stock Unit
2026-01-02+14,000→ 14,000 total→ Common Stock (14,000 underlying)
Footnotes (3)
- [F1]Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2024 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the option shall vest on the one (1) year anniversary of the Vesting Commencement Date, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean January 2, 2026.
- [F2]Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
- [F3]Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2024 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the RSUs subject to the award shall vest on the one (1) year anniversary of the RSU Grant Date, and one eighth (1/8th) of the RSUs subject to the award shall vest every six (6) months thereafter on the same day of the month as the RSU Grant Date (and if there is no corresponding day, on the last day of the month). "RSU Grant Date" shall mean January 2, 2026.
Documents
Issuer
LENZ Therapeutics, Inc.
CIK 0001815776
Entity typeother
Related Parties
1- filerCIK 0001706176
Filing Metadata
- Form type
- 4
- Filed
- Jan 5, 7:00 PM ET
- Accepted
- Jan 6, 4:21 PM ET
- Size
- 8.8 KB